IMPACT Series to the Rescue in Puerto Rico

Following the hurricane devastation in Puerto Rico, Omega was able to provide island customers with shorten lead times on select packaging equipment so they could help revive their medical manufacturing economy. 

Read the article on Omega's IMPACT Series and AbbVie, Inc., which Healthcare Packaging recently published:

Learn More About the IMPACT Series

Omega Entered Into Manufacturing Agreement to Offer Unit Dose Solutions

Omega has entered into a Manufacturing Agreement with Mactec Corporation to provide its customers with highly engineered unit dose packaging solutions. The companies shall soon finalize a Sales, Marketing, and Service Agreement.

For more information, watch this video (filmed at the recent Pack Expo in Las Vegas) hosted on Packaging World's website.

Omega Partners With Mactec to Offer Unit Dose / Blister Packaging

Omega Design has announced a strategic partnership with MACTEC Packaging Technologies (, which offers state-of-the-art blister machines for small format production of pharmaceutical and health & beauty aid products, including R&D and clinical trial applications.

See the Press Releases:

Packaging + Processing OEM features Omega on Workforce Development

The summer 2017 edition of Packaging + Processing OEM magazine features an in-depth profile of Omega Design.  Be sure to check out the article - Harvesting fruit from the STEM, by Matt Reynolds, editorial director - which looks at how Omega Design's commitments to external workforce development and internal training have it primed to tackle whatever the pharma industry has in store for the next generation.

Read the Harvesting fruit from the STEM here.

Process Strategies for Serialization Success

Excerpt from Serialization Countdown's April 17, 2017 online article by Keren Sooke, Director of Editorial Content at PMMI Media Group:

When we hear success stories, we often look for patterns that we can apply in our own lives. Serialization in pharmaceutical packaging is no exception. During a presentation at the Healthcare Packaging & Processing Conference co-located with this year’s PACK EXPO East in Philadelphia, Glenn Siegele, President and CEO at Omega Design Corporation, explained that serialization success stories share common themes. Each story has a clearly defined process strategy and a path to implementation. The underlining message in this presentation was to emphasize that serialization solutions may be unique to each application, but there are common approaches to solving them.

To read more of this article and learn of Glenn Siegele's presentation, refer to:


Pharma Expo Q&A with Chris Siegele

Omega's Serialization Specialist, Chris Siegele, answered an exclusive Pharmaceutical Processing questionnaire to share more about Omega Design, its technologies, and some of the upcoming trends in the industry.

Some of the questions addressed include:

  • Tell us about your company. Specifically, what do you do and what are some of the areas that you excel in?
  • What are some of the major innovations that have taken place in your industry in recent years? How has it impacted operations?
  • What are the biggest challenges in your industry? How have companies endeavored to address this?
  • Where do you see the most room for growth within your industry?
  • What are the biggest markets of your industry and why do you think that is?

Click here to read the answers.


Press Release: Omega becomes partner-in-residence at Systech Headquarters

Omega Design Corporation, a global provider of packaging machinery, serialization solutions, and bottle unscrambling technology has become a partner-in-residence at Systech International, based in Princeton, NJ, a global leader in serialization, track-and-trace, authentication, and trusted consumer engagement.

Read more at:

Track and Trace Roundtable in American Pharmaceutical Review

Glenn Siegele, President of Omega Design Corporation, was one of three featured panelists in a serialization roundtable article published in the American Pharmaceutical Review.

Questions asked include:

  • Many regulations for track-and trace and serialization are still being finalized. What advice can you give to a pharma company that wants to be prepared?
  • What anti-counterfeiting and anti-diversion technologies show the most promise to thwart illegal activities and why?
  • What are some of the biggest barriers to implement track and trace technologies? Cost? Complexity? Lack of regulatory guidelines?
  • What segment of the industry is really driving advances in track and trace/serialization? Government? Industry? Vendors? Why? Who has the most to gain, or lose?
  • Do you foresee regulatory agencies around the globe coming to a joint consensus on track and trace regulations in the near future?

Read the answers here.